Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Some deviations from the current OECD 402 and not GLP, purity and batch no. not given, but still very detailed and overall acceptable data.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1983
Report date:
1983

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
yes
Remarks:
active ingredient not tested up to limit dose
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
(R*,R*)-α,4-dimethyl-α-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol
EC Number:
208-205-9
EC Name:
(R*,R*)-α,4-dimethyl-α-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol
Cas Number:
515-69-5
Molecular formula:
C15H26O
IUPAC Name:
6-methyl-2-(4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol
Test material form:
semi-solid (amorphous): gel
Remarks:
migrated information: paste
Details on test material:
Bisabolol preparation

Test animals

Species:
rat
Strain:
other: BOR:WISW
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Firma Winkelmann, Versuchstierzucht, 4791 Borchen 1, Gartenstraße 300
- Weight at study initiation: male: 200 - 233 g. female: 144 - 185 g
- Housing: Collection caging (Macrolon type III/max. 5 rats)
- Diet: Ssniff-R Alleindiät
- Water: ad libitum
- Acclimation period: About 7 days

ENVIRONMENTAL CONDITIONS
- Temperature: 21 +/- 2 ° C
- Humidity: 45 - 55 %
- Photoperiod: 12 hours daily, from 7.00 a.m. - 7.00 p.m.

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: 8 x 5 cm
- Type of wrap if used: wrappings of plastic material for 24 hours


REMOVAL OF TEST SUBSTANCE
- Washing: The substance was removed with wet disposable gauze.
- Time after start of exposure: 24 h


TEST MATERIAL
- Amount(s) applied: 2.3 - 3.5 g (depending to body weight; 15 g/kg bw)

Duration of exposure:
24 h
Doses:
15 g/kg bw
No. of animals per sex per dose:
5 (scarificed skin) 5 (intact skin)
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations: 2 h, 4 h, 24 h, 48 h, 72 h, 7 and 14 days; skin alterations: 24 h, 3, 7 and 14 days; body weight: at day 0 and at day 14 (terminal necropsy)
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Preliminary study:
Pairs of two female rats (scarified) were employed in a preliminary range finding study. The dosage administrations were 15 and 5 g/kg of body weight. This preliminary study showed no mortalities.
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 750 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Based on the information given in the report ie. > 15000 mg/kg bw 5% Dragosanostol in Vaseline
Mortality:
No mortalities were observed.
Clinical signs:
In the tested dosage the sample did not induce any clinical-toxicological symptoms.
Body weight:
Body weight changes after the observation period showed a normal weight gain.
Gross pathology:
Necropsies performed on all animals at termination exhibited no gross pathological findings.
Other findings:
- Other observations: No skin alterations were observed.

Applicant's summary and conclusion